Colorado Alternative Health Care Ltd is categorized under Drug Brokers in Palisade, CO and active since 2009.
Colorado Alternative Health Care Ltd was established in 2009, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Drug Brokers business, which does work in the B2B market, and is classified as a Drug Brokers, under code number 424210 by the NAICS.
If you are seeking more information, feel free to contact Jesse Loughman at the company’s single location by writing to 125 Peach Avenue, Palisade, Colorado CO 81526 or by phoning (970) 424-5844. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Colorado Alternative Health Care Ltd |
| Contact Person: | Jesse Loughman |
| Address: | 125 Peach Avenue, Palisade, Colorado 81526 |
| Phone Number: | (970) 424-5844 |
| Annual Revenue (USD): | $100.000 to $499.999 |
| Founded: | 2009 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2B (Business to Business) |
| Business Category: | Drug Brokers |
| SIC Code: | 5122 |
| NAICS Code: | 424210 |
| Share This Business: |
Colorado Alternative Health Care Ltd was started in 2009 to provide professional Drug Brokers under the SIC code 5122 and NAICS code 424210. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.
Feel free to contact Jesse Loughman for inquiries that concern Colorado Alternative Health Care Ltd by calling the company number (970) 424-5844, as your correspondence is most welcome. Additionally, the physical location of the single location of Colorado Alternative Health Care Ltd can be found at the coordinates 39.111559,-108.353099 as well as the street address 125 Peach Avenue in Palisade, Colorado 81526.
For its online presence, you may visit Colorado Alternative Health Care Ltd’s website at and engage with its social media outlets through on Twitter and on Facebook.